A novel method that involves looking for disease-associated alpha-synuclein inside of neuron-derived extracellular vesicles — packets of cellular cargo that…
Marisa Wexler, MS
Marisa holds a Master of Science in cellular and molecular pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. Her areas of expertise include cancer biology, immunology, and genetics, and she has worked as a science writing and communications intern for the Genetics Society of America.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Marisa Wexler, MS
ABBV-951, AbbVie‘s experimental under-the-skin formulation of levodopa/carbidopa, was generally well-tolerated and increased average “on” time by more than three…
Among people with Parkinson’s disease, lower levels of a bacterial compound called butyrate in the gut are associated with…
Among people with Parkinson’s undergoing deep brain stimulation (DBS), those who receive stimulation in a certain brain region…
Analyses that estimate the length of a person’s vocal tract, which involves controlling muscles used in speech, could help to…
Inbrija, an approved treatment for “off” episodes of Parkinson’s disease, has now been launched in Germany. The medication…
Two European pharma companies have teamed up to create a technology platform that will help people with Parkinson’s disease…
StrivePD, a Rune Labs‘Â app that collects motor symptom data for people with Parkinson’s disease via measurements recorded by…
A soft, stretchable sensor called NeuroString could be used for measuring the activity of neurotransmitters — chemical messengers that nerve…
Levels of antibodies against synuclein proteins are lower in people with Parkinson’s disease than in heathy individuals, but these…